Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis

References

• Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. The pathogenic role of tissue resident immune cells in psoriasis. Trends Immunol. 2007; 28:51–57.
   Google Scholar
• Bos JD, de Rie MA, Teunissen MBM, Piskin G. Psoriasis: Dysregulation of innate immunity. Br J Dermatol. 2005; 152:1098–1107.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 2008; 128:1207–1211.
   PubMed Web of Science ®Google Scholar
• Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suárez-Fariñas M, Cardinale I, Khatcherian A, Gonzalez J, Pierson KC, White TR, Pensabene C, Coats I, Novitskaya I, Lowes MA, Krueger JG. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008; 159:1092–1102.
   PubMed Web of Science ®Google Scholar
• Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy. 2005; 4:329–334.
   PubMedGoogle Scholar
• Albanesi C, De Pità O, Girolomoni G. Resident skin cells in psoriasis: A special look at the pathogenetic functions of keratinocytes. Clin Dermatol. 2007; 25:581–588.
   PubMed Web of Science ®Google Scholar
• Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ, DiGiovanni J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005; 11:43–49.
   PubMed Web of Science ®Google Scholar
• Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, Krampert M, Goebeler M, Gillitzer R, Israel A, Krieg T, Rajewsky K, Haase ITNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 Nature. 2002; 417:861–866.
   Google Scholar
• Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, Scheuch H, Angel P, Tschachler E, Wagner EF. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature. 2005; 437:369–375.
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ. Skin innate immune system in psoriasis: Friend or foe?. J Clin Invest. 1999; 104:1161–1164.
   PubMedGoogle Scholar
• Ottaviani C, Nasorri F, Bedini C, De Pità O, Girolomoni G, Cavani A. CD56brightCD16neg NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006; 36:118–128.
   PubMed Web of Science ®Google Scholar
• Fantuzzi F, Del Giglio M, Gisondi P, Girolomoni G. Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis. Expert Opin Ther Targets. 2008; 12:1085–1096.
   PubMed Web of Science ®Google Scholar
• Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J Exp Med. 2005; 202:135–143.
   PubMed Web of Science ®Google Scholar
• Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004; 5:1219–1226.
   PubMed Web of Science ®Google Scholar
• Liu YJ. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol.. 2005; 23:275–306.
   PubMed Web of Science ®Google Scholar
• Colonna M, Cella M. Crosspresentation: Plasmacytoid dendritic cells are in the business. Immunity. 2007; 27:419–421.
   Google Scholar
• Sapoznikov A, Fischer JA, Zaft T, Krauthgamer R, Dzionek A, Jung S. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J Exp Med. 2007; 204:1923–1933.
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E, Moderer M, Rothenfusser S, Wetzel S, Endres S, Hartmann G. Plasmacytoid dendritic cells: A new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol. 2002; 119:1096–1102.
   PubMed Web of Science ®Google Scholar
• Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S, Fortugno P, Gonzalvo-Feo S, Franssen JD, Parmentier M, De Pità O, Girolomoni G, Sozzani S. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med. 2009; 206:249–258.
   PubMed Web of Science ®Google Scholar
• Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, Borrow P, Tough DF. Cross-priming of CD8-T cells stimulated by virus-induced type I interferon. Nat Immunol. 2003; 4:1009–1015.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 1998; 8:591–599.
   PubMed Web of Science ®Google Scholar
• Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res. 2003; 23:513–522.
   PubMed Web of Science ®Google Scholar
• Eriksen KW, Lovato P, Skov L, Krejsgaard T, Kaltoft K, Geisler C, Ødum N. Increased sensitivity to interferon-alpha in psoriatic T cells. J Invest Dermatol. 2005; 125:936–944.
   PubMed Web of Science ®Google Scholar
• Schmid P, Itin P, Cox D, McMaster GK, Horisberger MA. The type I interferon system is locally activated in psoriatic lesions. J Interferon Res. 1994; 14:229–234.
   PubMedGoogle Scholar
• Fah J, Pavlovic J, Burg G. Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem. 1995; 43:47–52.
   PubMed Web of Science ®Google Scholar
• Gilliet M, Conrad C, Geiges M, Cozzio A, Thürlimann W, Burg G, Nestle FO, Dummer R. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol. 2004; 140:1490–1495.
   PubMed Web of Science ®Google Scholar
• Ketikoglou I, Karatapanis S, Elefsiniotis I, Kafiri G, Moulakakis A. Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. Eur J Dermatol. 2005; 15:107–109.
   PubMed Web of Science ®Google Scholar
• Hida S, Ogasawara K, Sato K, Abe M, Takayanagi H, Yokochi T, Sato T, Hirose S, Shirai T, Taki S, Taniguchi T. CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity. 2000; 13:643–655.
   PubMed Web of Science ®Google Scholar
• Yao Y, Richman L, Morehouse C, de los Reyes M, Higgs BW, Boutrin A, White B, Coyle A, Krueger J, Kiener PA, Jallal B. Type I interferon: Potential therapeutic target for psoriasis?. PLoS ONE. 2008; 3:e2737.
   PubMed Web of Science ®Google Scholar
• van de Fits L, van der Wel LI, Laman JD, Prens EP, Verschuren MC. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered. J Invest Dermatol. 2004; 122:51–60.
   Google Scholar
• Frohm M, Agerberth B, Ahangari G, Stâhle-Bäckdahl M, Lidén S, Wigzell H, Gudmundsson GH. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem. 1997; 272:15258–15263.
   PubMed Web of Science ®Google Scholar
• Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schröder JM, Liu YJ, Gilliet M. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007; 449:564–569.
   PubMed Web of Science ®Google Scholar
• Diacovo TG, Blasius AL, Mak TW, Cella M, Colonna M. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J Exp Med. 2005; 202:687–696.
   PubMed Web of Science ®Google Scholar
• Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, Marrelli S, Vecchi A, Franssen JD, Communi D, Massardi L, Sironi M, Mantovani A, Parmentier M, Facchetti F, Sozzani S. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med. 2005; 201:509–515.
   PubMed Web of Science ®Google Scholar
• Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, Communi D, Parmentier M, Majorana A, Sironi M, Tabellini G, Moretta A, Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 2007; 109:3625–3632.
   PubMed Web of Science ®Google Scholar
• Christophers ESW. 2003. Psoriasis. In: Fitzpatrick TB, Wolff K, Freedberg IM, Austen KF. editors. Dermatology in general medicine. New York, NY: McGraw-Hill489–514.
   Google Scholar
• Onuma S. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol. 1994; 21:223–232.
   PubMedGoogle Scholar
• Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003; 198:977–985.
   PubMed Web of Science ®Google Scholar
• Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M. Plasmacytoid monocytes migrate to inflamed lymphnodes and produce large amounts of type I interferon. Nat Med. 1999; 5:919–923.
   PubMed Web of Science ®Google Scholar
• Sozzani S. Dendritic cell trafficking: More than just chemokines. Cytokine Growth Factor Rev. 2005; 16:581–592.
   PubMed Web of Science ®Google Scholar
• Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M, Communi D. Neutrophil-mediated maturation of chemerin: A link between innate and adaptive immunity. J Immunol. 2005; 175:487–493.
   PubMed Web of Science ®Google Scholar
• Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, Handel TM, Butcher EC. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem. 2005; 280:34661–34666.
   PubMed Web of Science ®Google Scholar
• Zabel BA, Nakae S, Zúñiga L, Kim JY, Ohyama T, Alt C, Pan J, Suto H, Soler D, Allen SJ, Handel TM, Song CH, Galli SJ, Butcher EC. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med. 2008; 205:2207–2220.
   PubMed Web of Science ®Google Scholar
• Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med. 2008; 205:767–775.
   PubMed Web of Science ®Google Scholar